{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:15:44Z","timestamp":1792192544301,"version":"4.4.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients newly diagnosed with cancer represent a population at highest risk for stroke. The objective of this systematic review and meta-analysis was to estimate the incidence of stroke in the first year following a new diagnosis of cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched MEDLINE and EMBASE from January 1980 to June 2021 for observational studies that enrolled adults with a new diagnosis of all cancers excluding non-melanoma skin cancer, and that reported the incidence of stroke at 1 year. PRISMA guidelines for meta-analyses were followed. Two reviewers independently extracted data and appraised risk of bias. We used the Dersimonian and Laird random effects method to pool cumulative incidences after logit transformation, and reported pooled proportions as percentages. Statistical heterogeneity was assessed using the <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> statistic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12,083 studies were screened; 41 studies were included for analysis. Data from 2,552,121 subjects with cancer were analyzed. The cumulative incidence of total stroke at 1 year was 1.4% (95% CI 0.9\u20132.2%), while the pooled incidence of ischemic stroke was 1.3% (95% CI 1.0\u20131.8%) and 0.3% (95% CI 0.1\u20130.9%) for spontaneous intracerebral hemorrhage (ICH), with consistently high statistical heterogeneity (&amp;gt;99% <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The estimated incidence of stroke during the first year after a new diagnosis of cancer is 1.4%, with a higher risk for ischemic stroke than ICH. Cancer patients should be educated on the risk of stroke at the time of diagnosis. Future studies should evaluate optimal primary prevention strategies in this high-risk group of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:ext-link>https:\/\/osf.io\/ucwy9\/<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.966190","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:21:06Z","timestamp":1663647666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Incidence of stroke in the first year after diagnosis of cancer\u2014A systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ronda","family":"Lun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Carole","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak B.","family":"Navi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar","family":"Dowlatshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0256825","DOI":"10.1371\/journal.pone.0256825","article-title":"Incidence of stroke in the first year after diagnosis of cancer-a protocol for systematic review and meta-analysis","volume":"16","author":"Lun","year":"2021","journal-title":"PLoS ONE."},{"key":"B2","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane\n            HigginsJPT\n            ThomasJ\n            ChandlerJ\n            CumpstonM\n            LiT\n            PageMJ\n            WelchVA\n          2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13287-019-1336-4","article-title":"Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies","volume":"10","author":"Shi","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"Role of clinical trial participation in cancer research: barriers, evidence, and strategies","volume":"35","author":"Unger","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Meet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/caac.21638","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B8","unstructured":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality if Nonrandomized Studies in Meta-Analyses. The Ottawa Hospital Research Institute\n            WellsGA\n            SheaB\n            O'ConnellD\n            PetersonJ\n            WelchV\n            LososM"},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2025","DOI":"10.1212\/WNL.0000000000005636","article-title":"New diagnosis of cancer and the risk of subsequent cerebrovascular events","volume":"90","author":"Navi","year":"2018","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood-2009-12-257519","article-title":"High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study","volume":"116","author":"Libourel","year":"2010","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","article-title":"Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden","volume":"48","author":"Z\u00f6ller","year":"2012","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/STROKEAHA.118.021373","article-title":"Risk of ischemic and hemorrhagic strokes in occult and manifest cancers","volume":"49","author":"Andersen","year":"2018","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/cncr.32703","article-title":"Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls","volume":"126","author":"Bigelow","year":"2020","journal-title":"Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0133","DOI":"10.1097\/MD.0000000000010133","article-title":"Higher stroke incidence in the patients with pancreatic cancer: a nation-based cohort study in Taiwan","volume":"97","author":"Chan","year":"2018","journal-title":"Medicine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00404-013-2827-7","article-title":"nationwide population-based retrospective cohort study: decreased risk of stroke in cervical cancer patients after receiving treatment","volume":"288","author":"Chang","year":"2013","journal-title":"Arch Gynecol Obstet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.clml.2017.06.011","article-title":"Elevated cardiovascular disease risk in patients with chronic myelogenous leukemia seen in community-based oncology practices in the United States","volume":"17","author":"Coutinho","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"B20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41391-019-0150-5","article-title":"Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy","volume":"22","author":"Deka","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10552-016-0742-5","article-title":"Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer","volume":"27","author":"Du","year":"2016","journal-title":"Cancer Causes Control."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.clcc.2015.05.007","article-title":"Risks of venous thromboembolism, stroke, heart disease, and myelodysplastic syndrome associated with hematopoietic growth factors in a large population-based cohort of patients with colorectal cancer","volume":"14","author":"Du","year":"2015","journal-title":"Clin Colorectal Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djh285","article-title":"Stroke risk and tamoxifen therapy for breast cancer","volume":"96","author":"Geiger","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"B24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijrobp.2013.06.009","article-title":"Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer","volume":"87","author":"Hong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fneur.2019.00052","article-title":"The long-term effect of cancer on incident stroke: a nationwide population-based cohort study in Korea","volume":"10","author":"Jang","year":"2019","journal-title":"Front Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.21037\/atm-20-5222","article-title":"Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: a nationwide cohort study","volume":"8","author":"Kim","year":"2020","journal-title":"Ann Transl Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1055\/s-0040-1708484","article-title":"The effect of chemotherapy on stroke risk in cancer patients","volume":"120","author":"Kitano","year":"2020","journal-title":"Thromb Haemost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1038\/s41598-021-83665-4","article-title":"The incidence of myocardial infarction and stroke in head and neck cancer patients","volume":"11","author":"Kwon","year":"2021","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hon.2340","article-title":"Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study","volume":"35","author":"Lee","year":"2017","journal-title":"Hematol Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1038\/s41598-021-89867-0","article-title":"High 1-year risk of stroke in patients with hepatocellular carcinoma: a nationwide registry-based cohort study","volume":"11","author":"Hsu","year":"2021","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/cen.13990","article-title":"Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease","volume":"91","author":"Toulis","year":"2019","journal-title":"Clin Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7150\/jca.36468","article-title":"Novel oral anticoagulant versus warfarin in cancer patients with atrial fibrillation: an 8-year population-based cohort study","volume":"11","author":"Wu","year":"2020","journal-title":"J Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2169\/internalmedicine.2415-18","article-title":"Oral anticoagulants in Japanese patients with atrial fibrillation and active cancer","volume":"58","author":"Yasui","year":"2019","journal-title":"Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/rth2.12223","article-title":"The risk of arterial thromboembolic events after cancer diagnosis","volume":"3","author":"Navi","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"key":"B36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaccao.2021.02.007","article-title":"Arterial thromboembolism in cancer patients: a danish population-based cohort study","volume":"3","author":"Mulder","year":"2021","journal-title":"JACC CardioOncology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/bjh.17018","article-title":"Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters","volume":"193","author":"Gurnari","year":"2021","journal-title":"Br J Haematol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00408-013-9485-1","article-title":"Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study","volume":"191","author":"van Herk-Sukel","year":"2013","journal-title":"Lung."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1200\/JCO.2016.71.4204","article-title":"Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer: a nationwide cohort study","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/coa.12064","article-title":"Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: a national database, controlled cohort study","volume":"38","author":"Chu","year":"2013","journal-title":"Clin Otolaryngol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00432-020-03412-6","article-title":"Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study","volume":"147","author":"Kim","year":"2021","journal-title":"J Cancer Res Clin Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4070\/kcj.2017.0328","article-title":"Effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with newly diagnosed cancer","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1741-7015-12-53","article-title":"Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study","volume":"12","author":"Kuan","year":"2014","journal-title":"BMC Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1336","DOI":"10.1097\/MD.0000000000001336","article-title":"Risk of ischemic stroke in patients with gastric cancer: a nationwide population-based cohort study","volume":"94","author":"Kuan","year":"2015","journal-title":"Medicine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.breast.2019.05.017","article-title":"Current status of anticoagulation in patients with breast cancer and atrial fibrillation","volume":"46","author":"Pardo Sanz","year":"2019","journal-title":"Breast Edinb Scotl."},{"key":"B47","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11239-018-1790-3","article-title":"Thromboembolism and bleeding in patients with cancer and mechanical heart valves","volume":"47","author":"Plaja","year":"2019","journal-title":"J Thromb Thrombolysis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2147\/CLEP.S216787","article-title":"Vascular diseases in patients with chronic myeloproliferative neoplasms - impact of comorbidity","volume":"11","author":"Frederiksen","year":"2019","journal-title":"Clin Epidemiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-8-41","article-title":"Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"Radiat Oncol Lond Engl."},{"key":"B50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1182\/blood-2015-02-626788","article-title":"Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study","volume":"126","author":"Donato","year":"2015","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1182\/blood-2017-02-767285","article-title":"Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin","volume":"129","author":"Mantia","year":"2017","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1001\/jama.296.24.2939","article-title":"Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years","volume":"296","author":"Carandang","year":"2006","journal-title":"JAMA."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1212\/WNL.0000000000011264","article-title":"Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies","volume":"96","author":"Zhang","year":"2021","journal-title":"Neurology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s11764-021-01122-7","article-title":"Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis","volume":"379","author":"Turner","year":"2021","journal-title":"J Cancer Surviv."},{"key":"B55","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1182\/blood-2018-06-860874","article-title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons","volume":"133","author":"Navi","year":"2019","journal-title":"Blood."},{"key":"B56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fneur.2019.00579","article-title":"Stroke rate increases around the time of cancer diagnosis","volume":"10","author":"Wei","year":"2019","journal-title":"Front Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","article-title":"Country-specific lifetime risks of stroke, 1990 and 2016","volume":"379","author":"Global","year":"2018","journal-title":"N Engl J Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"104560","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104560","article-title":"Risk of ischemic stroke and major bleeding in patients with atrial fibrillation and cancer","volume":"29","author":"Aspberg","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting strokeresults from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1753944719860676","DOI":"10.1177\/1753944719860676","article-title":"Predicting outcomes in patients with cancer and atrial fibrillation","volume":"13","author":"Gutierrez","year":"2019","journal-title":"Ther Adv Cardiovasc Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2017.05.006","article-title":"Cancer, atrial fibrillation, and stroke","volume":"155","author":"Fitzpatrick","year":"2017","journal-title":"Thromb Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11739-008-0124-4","article-title":"First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation","volume":"3","author":"Guzzetti","year":"2008","journal-title":"Intern Emerg Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2016.06.009","article-title":"Pathophysiology of cancer therapy-provoked atrial fibrillation","volume":"219","author":"Cheng","year":"2016","journal-title":"Int J Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/SLA.0000000000001626","article-title":"Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery","volume":"264","author":"Cardinale","year":"2016","journal-title":"Ann Surg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"Angelini","year":"2019","journal-title":"Am J Hematol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian cardiovascular society\/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1634\/theoncologist.2013-0239","article-title":"New oral anticoagulants and the cancer patient","volume":"19","author":"Short","year":"2014","journal-title":"Oncologist."},{"key":"B74","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-0716-1566-9_10","article-title":"Meta-analysis of proportions","volume":"2345","author":"Schwarzer","year":"2022","journal-title":"Methods Mol Biol Clifton NJ."},{"key":"B77","doi-asserted-by":"publisher","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ."},{"key":"B78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/bmj.321.7261.585","article-title":"Why we need a broad perspective on meta-analysis","volume":"321","author":"G\u00f8tzsche","year":"2000","journal-title":"BMJ."},{"key":"B79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of english-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies","volume":"28","author":"Morrison","year":"2012","journal-title":"Int J Technol Assess Health Care."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.966190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:21:11Z","timestamp":1663647671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.966190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":79,"alternative-id":["10.3389\/fneur.2022.966190"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.966190","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"966190"}}